title: L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
authors.affiliation: University Hospital Schleswig-Holstein, Vasculitis Center, Department of Rheumatology, Campus Lübeck and Klinikum Bad Bramstedt, Oskar-Alexander Straβe, 26, 24576 Bad Bramstedt, Germany. j.holle@klinikumbb.de
authors.forename: Julia U
authors.initials: JU
authors.lastname: Holle
mesh_terms: D000367:Age Factors; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood*; D015267:Churg-Strauss Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D055953:Microscopic Polyangiitis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D053146:Myeloblastin / Q000276:immunology*; D009195:Peroxidase / Q000276:immunology*; D011379:Prognosis; D012737:Sex Factors
chemical_list: D000893:Anti-Inflammatory Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D009195:Peroxidase; D053146:Myeloblastin